TRUIST FINANCIAL CORP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 92230 CHARLOTTE, NC

Back to VRTX Full portfolio

Position in VRTX

as of Mar 31, 2026 · filed Apr 27, 2026 Compact

Position Value

$51,106,055

-$6,104,802 QoQ

Shares Held

114,449

-9.3% QoQ

Ownership

0.045%

of shares outstanding

% of Portfolio

0.13%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

25 quarters on record

Voting authority Sole 54.761509493311436.ToString("F0")% Shared 0.09960768551931429.ToString("F0")% None 45.138882821169254.ToString("F0")%

Common Shares in VRTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

TRUIST FINANCIAL CORP holds $112,535,820 across 48 Biotechnology names. VRTX ranks #1 (45.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma This page	114,449	$51,106,055
2	REGN	Regeneron Pharmaceuticals, Inc.	40,108	$30,989,044
3	ARGX	Argenx SE	3,878	$2,831,908
4	ALNY	Alnylam Pharmaceuticals, Inc.	7,701	$2,548,029
5	INSM	INSMED Inc	15,416	$2,520,822
6	JAZZ	Jazz Pharmaceuticals plc	10,207	$1,929,631
7	EXEL	Exelixis, Inc.	32,818	$1,407,563
8	RPRX	Royalty Pharma plc	29,108	$1,396,310

All Filings in VRTX

Export CSV

25 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$51,106,055	114,449	-9.3%	Shares	Defined	2026-04-27
2025-12-31	$57,210,857	126,193	-12.3%	Shares	Defined	2026-02-02
2025-09-30	$56,342,895	143,864	-31.5%	Shares	Defined	2025-11-03
2025-06-30	$93,531,621	210,089	-6.2%	Shares	Defined	2025-07-18
2025-03-31	$108,585,134	223,970	+5.7%	Shares	Defined	2025-04-29
2024-12-31	$85,293,470	211,804	+0.9%	Shares	Defined	2025-01-31
2024-09-30	$97,629,127	209,919	-4.0%	Shares	Defined	2024-11-13
2024-06-30	$102,481,408	218,641	-2.0%	Shares	Defined	2024-08-21
2024-03-31	$93,262,628	223,111	-1.0%	Shares	Defined	2024-05-13
2023-12-31	$91,695,101	225,356	-0.8%	Shares	Defined	2024-02-02
2023-09-30	$78,958,886	227,063	+34.5%	Shares	Defined	2023-11-14
2023-06-30	$59,417,890	168,844	+5.1%	Shares	Defined	2023-08-01
2023-03-31	$50,632,692	160,703	-6.3%	Shares	Defined	2023-05-05
2022-12-31	$49,509,596	171,444	+57.9%	Shares	Defined	2023-02-17
2022-09-30	$31,437,673	108,578	+1.6%	Shares	Defined	2022-10-26
2022-06-30	$30,105,596	106,837	-3.7%	Shares	Defined	2022-07-22
2022-03-31	$28,960,883	110,974	+31.9%	Shares	Defined	2022-04-22
2021-12-31	$18,476,704	84,138	+3.6%	Shares	Defined	2022-02-14
2021-09-30	$14,738,117	81,251	+115.3%	Shares	Defined	2021-11-05
2021-06-30	$7,609,514	37,740	+0.2%	Shares	Defined	2021-08-16
2021-03-31	$8,091,681	37,655	-4.7%	Shares	Defined	2021-05-17
2020-12-31	$9,340,391	39,521	-6.6%	Shares	Defined	2021-11-19
2020-09-30	$11,514,755	42,315	+7.2%	Shares	Defined	2021-11-05
2020-06-30	$11,464,339	39,490	+13.1%	Shares	Defined	2021-11-16
2020-03-31	$8,305,880	34,906	—	Shares	Defined	2021-11-05
No filing history on record for this holder in this stock.